2don MSN
CRISPR enzyme precisely detects and shreds DNA in cancer mutations once considered 'undruggable'
In 2020, Jennifer Doudna won the Nobel Prize in chemistry for her work on the CRISPR-Cas9 gene-editing technology that allows ...
A signaling system known as the Wnt pathway plays a central role in how cells in the intestine grow, divide and renew ...
Researchers discovered that mutations linked to blood cancers may help trigger Alzheimer’s disease by creating overly ...
Morning Overview on MSN
A phase 1/2 trial just reported exceptional disease control on pancreatic cancer using daraxonrasib — a targeted drug aimed at the mutation doctors once called untreat…
For roughly four decades, oncologists had a grim shorthand for the most common genetic driver of pancreatic cancer: ...
A new drug targets RAS cancer-causing cells in the pancreas, nearly doubling survival rates in clinical trials. Here's how ...
A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 ...
For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic ...
As we age, our cells acquire cancer-causing mutations, but mutations alone are rarely enough to start a tumor. An ...
Sperm from a single donor in Europe has reportedly been used to conceive at least 67 pregnancies, although the donor carried a rare cancer-causing mutation. The donor’s mutation has been linked to ...
Although cancer treatments are improving fast, prevention has so far been mostly about promoting a healthy lifestyle. But ...
New findings presented at ASCO 2026 show that a powerful drug combination works better than chemotherapy for triple-negative ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results